Oncology & Metabolism News
Research collaboration involving the University of Sheffield proposes a set of measurements that can be used as a toolkit to assess bone, joint and muscle health
New method will provide a consistent and holistic way to measure the gradual loss of function that everyone experiences as they get older
World-leading oncologist joins University of Sheffield to further accelerate translational cancer research
A world-leading oncologist has joined the University of Sheffield, helping to further accelerate translational cancer research in the region.
A ground breaking research project into a rare type of bone cancer which affects young adults, has been made possible thanks to the legacy of an inspirational teenager.
Categorised under: Oncology
Research will help to reduce the amount of preterm birth in low and middle income countries in line with the Sustainable Development Goals of the United Nations Funding will bring improved guidance for antenatal care in order to prevent, recognise and manage preterm birth better.
University of Sheffield scientists discover nine novel genes for osteoarthritis
10 million people suffer from osteoarthritis in the UK – a degenerative disease in which a person’s joints become damaged, stop moving freely and become painful
Findings could open the door to new targeted therapies
Osteoarthritis is a leading cause of disability worldwide
First licensed treatment in Europe specially designed for use in children with adrenal insufficiency
Adrenal insufficiency means not enough cortisol is produced – a potentially fatal difficency
University spin-out company’s first product receives marketing authorisation from the European Commission
Two grants totalling £600,000 awarded to pioneering prostate cancer research projects at the University of Sheffield
The innovative research aims to stop the spread of cancer and prevent the disease from growing back after primary treatment
Prostate cancer is the most common cancer in men and the disease kills one man every 45 minutes in the UK
Breast cancer charity Second Hope awards first ever PhD studentship to researchers at the University of Sheffield
A research team at the University of Sheffield has been awarded a £100,000 grant by the charity Second Hope to investigate why breast cancer spreads to the skeleton in 80% of patients who develop Secondary Breast Cancer.
New research finds high prevalence of vitamin D deficiency in IBS patients – regardless of their ethnicity
Vitamin D supplements could help to ease IBS symptoms such as bloating, stomach cramps and constipation
IBS is a condition which affects two in 10 people in the UK
New therapy discovered at University of Sheffield has become first treatment approved for secondary breast cancer patients with BRCA gene
US Food and Drug Administration (FDA) has expanded the use of Lynparza (olaparib) to certain breast cancer patients
Around 1.7 million cases of breast cancer are diagnosed worldwide each year, with 50,000 in the UK
Community screening for osteoporosis could prevent more than a quarter of hip fractures in older women, according to new research from the University of Sheffield
A University of Sheffield academic has been honoured with the Distinguished Service Medal from the British Institute of Radiology (BIR) for her commitment to and involvement with the organisation.
Genetic test could help fight secondary breast cancer
New genetic test could benefit thousands of breast cancer patients at risk of developing aggressive secondary tumours
Bone strengthening drugs can help prevent the disease from spreading to the bone
New test uses Magnetic Resonance Spectroscopy to examine the molecules in live sperm
Early data suggests it could discriminate between populations of good and poor sperm
Scientists claim it might be useful to improve diagnosis of sperm problems because it is non-destructive, so the sperm examined could be used in fertility treatments after analysis
Doctors and scientists from Sheffield Teaching Hospitals NHS Foundation Trust and the University of Sheffield to use pioneering technology to develop and test new device that could predict onset of premature labour
Small pencil-tip probe detects properties that are known to change in the cervix prior to the onset of premature labour
Once tested, all pregnant women could be offered an assessment of their risk of premature labour during their mid-pregnancy anomaly scan, between the 18th and 20th week of pregnancyA NEW ‘next generation’ device which could help doctors reliably predict the risk of preterm birth is to be developed by Sheffield Teaching Hospitals NHS Foundation Trust and the University of Sheffield thanks to funding from the National Institute for Health Research (NIHR).